Neuland Laboratories Limited (NSE:NEULANDLAB)
India
· Delayed Price · Currency is INR 14,744
+299 (2.07%)
Apr 29, 2026, 11:30 AM IST
Neuland Laboratories Company Description
Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Neuland Laboratories Limited
| Country | India |
| Founded | 1984 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,794 |
| CEO | Davuluri Rao |
Contact Details
Address: Phoenix IVY Building Hyderabad, 500033 India | |
| Phone | 91 40 6761 1600 |
| Website | neulandlabs.com |
Stock Details
| Ticker Symbol | NEULANDLAB |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE794A01010 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Davuluri Saharsh Rao | Chief Executive Officer and MD |
| Dr. Davuluri Rama Mohan Rao | Executive Chairman and Chief Promoter and Member of Scientific Advisory Board |
| Davuluri Sucheth Rao | Executive Vice Chairman |
| Abhijit Majumdar | Chief Financial Officer |
| Dr. Sharadsrikar Venkatesan Kotturi | Chief Scientific Officer and Member of Scientific Advisory Board |
| Ajitabh Singh | Chief Information Officer |
| Sarada Bhamidipati | Company Secretary and Compliance Officer |
| Sudheer Yarabolu | Global Head Sales and BD |
| Hemchandra Peruvelli | Chief Human Resources Officer |
| Sundar Narsimhan | Chief Procurement Officer |